Emmanuel Velazquez-Alvarez: Bridging Innovation and Clinical Practice
Emmanuel Velazquez-Alvarez, Product Manager at Technoclone, shared a post on LinkedIn:
“Diagnostics is indeed a very dynamic area, with significant advances in automation, assay sensitivity, and data integration.
From my perspective, one of the main challenges remains translating technological innovation into routine clinical workflows.
Factors such as standardization across laboratories, regulatory requirements, cost effectiveness, and clinician familiarity can often slow adoption despite clear technical benefits.
Bridging that gap while maintaining diagnostic accuracy and supporting faster clinical decisions will continue to be a key focus for the field.
It was inspiring to meet and exchange ideas with colleagues, researchers, clinicians, and leading experts from around the world who are shaping the future of thrombosis, hemostasis, and healthcare innovation.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Sep 5, 2026, 02:28N. Mariana S. Vasquez: Warm vs Cold Autoimmune Hemolytic Anemia for USMLE/NBME Questions
-
Sep 4, 2026, 22:03Maeve Crowley: Haemophilia Treatment Over the Decades and Hope for the Future
-
Sep 4, 2026, 22:01Lama Skieker: Understanding Thrombocytopenia in Malaria
-
Sep 4, 2026, 22:00Hiten Patel: How an IVC Filter Helps Prevent Pulmonary Embolism
-
Sep 4, 2026, 21:54Gianluca Costamagna: Investigating the Link Between Cancer and Acute Ischemic Stroke
-
Sep 4, 2026, 21:50Ben Creagh-Brown: PRAGUE-26 and HI-PEITHO Similar Benefits With Important Differences
-
Sep 4, 2026, 21:48Jin-Xiong She: Homocysteine beyond Heart Disease – The Methylation-Mobility Connection
-
Sep 4, 2026, 21:44Aravind Palraj: Anemia of Chronic Inflammation is Not Just “Iron Deficiency”
-
Sep 4, 2026, 21:41Chokri Ben Lamine: Fundamental HSCT Workshop for Hematology Fellows at HAAG 2026